Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Know Labs Inc (KNWN)

Know Labs Inc (KNWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Know Labs, Inc. Announces NYSE American Listing Approval

Know Labs, Inc. (OTCQB: KNWN), an emerging leader of non-invasive medical diagnostic technology, today announced that, subject to official authorization and meeting all requirements (including the price...

KNWN : 2.5300 (-3.44%)
Know Labs Provides Update on IRB-Approved Internal Trial of Non-Invasive Glucose Monitoring Technology

Know Labs, Inc. (OTCQB: KNWN) , an emerging developer of non-invasive medical diagnostic technology, today released a video update on the IRB-approved internal trial the Company has been conducting at...

KNWN : 2.5300 (-3.44%)
Know Labs Files S-1 for New Share Offering, Seeks Uplist to NYSE American Exchange

Know Labs, Inc. (OTCQB: KNWN) an emerging developer of non-invasive medical diagnostic technology, today announced it has filed a Form S-1 registration statement for a proposed new offering of 3 million...

KNWN : 2.5300 (-3.44%)
Know Labs Expands Leadership Team, Adds Chief Financial Officer and Chief Product Officer, As It Gets Closer to FDA Clearance Application

Know Labs, Inc. (OTCQB: KNWN) , an emerging leader in non-invasive medical diagnostic technology, today announced the addition of two senior executives, each of whom will play a pivotal role in guiding...

KNWN : 2.5300 (-3.44%)
New Foundational Patents Secure Multiple Growth Opportunities for Know Labs and Its Bio-RFIDâ„¢ Non-Invasive Diagnostic Technology

Know Labs, Inc. (OTCQB: KNWN) , an emerging leader in non-invasive medical diagnostics, today announced it has been granted two new foundational patents that add significant value to its IP portfolio and...

KNWN : 2.5300 (-3.44%)
Know Labs Receives IRB Approval to Begin Internal Clinical Trial of Non-Invasive Glucose Monitoring Technology Bio-RFIDâ„¢

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced it has received approval from an independent Institutional Review Board (IRB) for the protocol of...

KNWN : 2.5300 (-3.44%)
Know Labs Launches Subsidiary, AI Mind Inc., Generates $4.2M in NFT Revenue to Fund Continued Non-Invasive Glucose Monitoring Device Development

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced that a new subsidiary created to work with the company’s Artificial Intelligence (AI) Deep Learning...

KNWN : 2.5300 (-3.44%)
New Test Data Confirm Particleâ„¢ Bulb from Know Labs Successfully Inactivates SARS-CoV-2 Variants

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced that new independent test data have confirmed the efficacy of a light bulb produced by its wholly...

KNWN : 2.5300 (-3.44%)
New Tests Show Know Labs Bio-RFIDâ„¢ Technology Delivers Blood Glucose Readings Comparable to FDA-Cleared Devices

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today published a new report on its non-invasive platform technology, Bio-RFID TM , comparing its clinical accuracy...

KNWN : 2.5300 (-3.44%)
Know Labs Expands Non-Invasive Glucose Monitoring Product Portfolio with Introduction of New KnowUâ„¢ Diagnostic Device

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today introduced the KnowUâ„¢, a new portable medical-grade glucose monitoring device that utilizes Bio-RFIDâ„¢, Know...

KNWN : 2.5300 (-3.44%)

Barchart Exclusives

Is Your Ford Stock Dividend Safe Amid the EV Price War?
Ford's dividend yield is currently around 5%, which is over three times the S&P 500's dividend yield. While Ford's yield looks mouthwatering, are the payouts safe amid ongoing EV industry turmoil? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar